|
Lisa Gable, CEO of FARE, has managed several major turning points within her work experience. At FARE, with food allergy, the organization is at several major inflection points with the first peanut allergy therapy receiving FDA approval, gene editing in agriculture, consumer packaged goods and artificial intelligence. Lisa joins Maureen to help leaders understand when they are at an inflection point and how to optimize and maximize results for their organization and society’s benefit.
|
